Local Pensions Partnership Investment 13F: Adds $8M to TMO Stake

Local Pensions Partnership Investment boosted its stake in Thermo Fisher Scientific Inc. (TMO) by 11,900 shares in a filing on October 26, 2026.

TMO Thermo Fisher Scientific Inc.

$684.89 ▲ +15.91% year to date

1M 3M YTD

Daily close · Oct 26, 2026

What Changed in Local Pensions Partnership Investment's Thermo Fisher Scientific Position

The fund added 11,900 shares, which is a 3.9% increase from its previous total of 304,551 shares. The reported value of this new stake is approximately $8.04 million.

Where Thermo Fisher Scientific Fits in Local Pensions Partnership Investment's Portfolio

Thermo Fisher Scientific accounts for 6.64% of the fund's total reported value of $3.22 billion, ranking it 8th among the 33 positions in the portfolio.

Other Institutional Activity in Thermo Fisher Scientific

Several other funds made notable changes to their positions in Thermo Fisher Scientific. J. Safra Sarasin Holding reduced its stake by 29,845 shares, leaving it with 31,334 shares valued at about $21.2 million. Marathon Asset Management cut its holdings by 15,520 shares, now holding 60,648 shares worth approximately $40.9 million. Alta Capital Management also trimmed its position by 32,509 shares, ending with 29,803 shares valued around $20.1 million.

Thermo Fisher Scientific Inc. Stock Down 0.4%

Thermo Fisher's shares recently traded around $673.82 as of October 27, 2026, which is about 1.6% below the event close of $684.89 on October 26. The stock's performance is important for investors to consider, especially in light of recent institutional trading activity.

Recent Earnings

Thermo Fisher Scientific reported trailing twelve-month revenue of approximately $47.35 billion and an EPS of $18.96. The company has shown a revenue growth rate of 9.1% year-over-year. The next earnings report is expected on January 28, 2027.

Dividend

Thermo Fisher Scientific pays an annual dividend of $1.88 per share, with a payout ratio of 9.7%.

Analysts Set New Price Targets

On October 22, 2026, Barclays maintained an Overweight rating on Thermo Fisher with a price target of $775. RBC Capital also maintained a Sector Perform rating with a target of $730. Additionally, TD Cowen and Stifel both maintained Buy ratings with targets of $810 and $775, respectively. Citigroup set a Buy rating with a target of $800 on October 23.

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a major player in the healthcare sector, providing life sciences solutions, analytical instruments, and laboratory products. The company operates through several segments, focusing on diagnostics and research, which positions it well in the growing healthcare market.

Bottom Line

Investors should keep an eye on Thermo Fisher's next earnings date on January 28, 2027, and watch for further filings as institutional interest continues to evolve. Local Pensions Partnership Investment's recent boost in shares reflects ongoing confidence in the company's performance.